THOMAS LEPRE: Open Payments
NPI 1073182606 · POMONA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 13 payments from 6 companies in 2025. Trend: 2023 $49 · 2024 $383 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: AMVUTTRA, LEQVIO, VERQUVO, FARXIGA, NEXLETOL, WAINUA, Kerendia.
Industry payments across NJ — which companies pay providers there.
